35629-71-1Relevant articles and documents
Novel Myocyte Enhancer Factor 2 (MEF2) modulators
-
Paragraph 0147-0149, (2019/08/20)
The present disclosure provides novel compounds capable of functioning as Myoctye Enhancer Factor 2 (MEF2) modulators, as well as compositions, pharmaceutical formulations, methods of synthesis and kits. Also provided are methods of treating a condition regulatable by MEF2 and/or MEF2 cofactors using the compounds, compositions, pharmaceutical formulations, and kits provided herein.
Derivatives of 2-aminooxazoles showing antiinflammatory activity.
Crank,Foulis
, p. 1075 - 1077 (2007/10/06)
-